New developments in combination chemotherapy of anti-human immunodeficiency virus drugs

Affiliations

Review

V A Johnson et al. Ann N Y Acad Sci. 1990.

. 1990:616:318-27.

doi: 10.1111/j.1749-6632.1990.tb17852.x.

¹ Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston 02114.

No abstract available

Similar articles

Combination antiretroviral therapy for HIV infection.
Fischl MA. Fischl MA. Hosp Pract (Off Ed). 1994 Jan 15;29(1):43-8. doi: 10.1080/21548331.1994.11442959. Hosp Pract (Off Ed). 1994. PMID: 8288688 Review.
Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.
De Clercq E. De Clercq E. Biomed Pharmacother. 1996;50(5):207-15. doi: 10.1016/0753-3322(96)87660-8. Biomed Pharmacother. 1996. PMID: 8949401 Review.
Agents for treating human immunodeficiency virus infection.
Acosta EP, Fletcher CV. Acosta EP, et al. Am J Hosp Pharm. 1994 Sep 15;51(18):2251-67; quiz 2286-7. Am J Hosp Pharm. 1994. PMID: 7801986 Review.
Correlations between the in vitro and in vivo activity of anti-HIV agents: implications for future drug development.
Yarchoan R, Broder S. Yarchoan R, et al. J Enzyme Inhib. 1992;6(1):99-111. doi: 10.3109/14756369209041358. J Enzyme Inhib. 1992. PMID: 1285306 Review.
Kijimicin: an inhibitor of human immunodeficiency virus in acutely and chronically infected cells.
Nakamura M, Ohno T, Kunimoto S, Naganawa H, Takeuchi T. Nakamura M, et al. J Antibiot (Tokyo). 1991 May;44(5):569-71. doi: 10.7164/antibiotics.44.569. J Antibiot (Tokyo). 1991. PMID: 2061199 No abstract available.

Antiretroviral Drugs Impact Autophagy with Toxic Outcomes.
Cheney L, Barbaro JM, Berman JW. Cheney L, et al. Cells. 2021 Apr 15;10(4):909. doi: 10.3390/cells10040909. Cells. 2021. PMID: 33920955 Free PMC article. Review.